Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 7696 AL 7710

Functional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease risk

Sugarman MA, Woodard JL, Nielson KA, Seidenberg M, Smith JC, Durgerian S, Rao SM.

Biochim Biophys Acta. 2012 Mar;1822(3):442-56. doi: 10.1016/j.bbadis.2011.09.016. Epub 2011 Oct 4.

Alzheimer disease biomarkers are associated with body mass index

Vidoni ED, Townley RA, Honea RA, Burns JM; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2011 Nov 22;77(21):1913-20. doi: 10.1212/WNL.0b013e318238eec1.

Changes in cognition

Albert MS.

Neurobiol Aging. 2011 Dec;32 Suppl 1(0 1):S58-63. doi: 10.1016/j.neurobiolaging.2011.09.010.

Obesity, leptin, and Alzheimer's disease

Lee EB.

Ann N Y Acad Sci. 2011 Dec;1243:15-29. doi: 10.1111/j.1749-6632.2011.06274.x.

Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages

Perovnik M, Simončič U, Jamšek J, Gregorič Kramberger M, Brumberg J, Meyer PT, Perani D, Caminiti SP, Brendel M, Stockbauer AC, Camacho V, Alcolea D, Vandenberghe R, Van Laere K, Ko JH, Lee CS, Pardini M, Lombardo L, Padovani A, Pilotto A, Ochoa-Figueroa MA, Davidsson A, Cháfer-Pericás C, Álvarez-Sánchez L, Garibotto V, Lemstra AW, Ferreira D, Morbelli SD, Tang CC, Eidelberg D, Trošt M; Alzheimer’s Disease Neuroimaging Initiative.

J Neurol Neurosurg Psychiatry. 2026 Mar 13;97(4):316-324. doi: 10.1136/jnnp-2025-336935.

Eye-brain coupling-mediated eye movement abnormalities as non-invasive biomarkers for mild cognitive impairment: A systematic review

Li Y, Feng J, Xie Y, Yao Q, Yu J, Xu S, Wang Z, Wang Q.

J Alzheimers Dis. 2026 May;111(1):90-101. doi: 10.1177/13872877261430597. Epub 2026 Mar 20.

Identifying risk factors of young-onset dementia and evaluating evidence hierarchy: a meta-analysis and umbrella review

Zhang J, Yang D, Liang J, Hu Y, Rao L, Huang J, Wu Q, Jiang B.

J Prev Alzheimers Dis. 2026 Mar;13(3):100467. doi: 10.1016/j.tjpad.2025.100467. Epub 2026 Jan 1.

Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease

Tropea TF, Stevenson PA, Flitter M, Meehan D, Morris A, Lu M, Iaccarino L, Collins EC, Hodsdon ME, Irwin D, Spindler M, Deik A, Dahodwala N, Cousins KAQ, Wolk DA, Shaw L, Weintraub D, Lee EB, Chen-Plotkin A, Mintun M, Siderowf A.

Ann Neurol. 2026 Jun;99(6):1428-1437. doi: 10.1002/ana.78201. Epub 2026 Mar 18.

Management of catatonia in Huntington disease: A scoping review

Miglis G, Kadan J, Noe G, Munjal S.

Gen Hosp Psychiatry. 2026 May 9;101:39-44. doi: 10.1016/j.genhosppsych.2026.05.004. Online ahead of print.

Executive Impairment in Huntington's Disease: Insights From a Systematic Review of the Literature

Migliore S, Marcaccio M, Di Pompeo I, Marano M, Curcio G.

Brain Behav. 2026 Feb;16(2):e71238. doi: 10.1002/brb3.71238.

[Huntington´s disease - overview]

Briem S, Bjornsson T, Stefansdottir V, Jonsson JJ, Sveinsson OA.

Laeknabladid. 2026 May;112(5):216-222. doi: 10.17992/lbl.2026.05.891.

[Rapidly progressive neurocognitive symptoms - consider rare aetiologies]

Badertscher J, Schoch G, Escher R, Waldegg G.

Praxis (Bern 1994). 2026 Mar;115(3):87-91. doi: 10.23785/PRAXIS.2026.03.006.

Predictors for survival in patients with Alzheimer's disease: a large comprehensive meta-analysis

Zheng X, Wang S, Huang J, Li C, Shang H.

Transl Psychiatry. 2024 Apr 10;14(1):184. doi: 10.1038/s41398-024-02897-w.

Sleep characteristics and risk of Alzheimer's disease: a systematic review and meta-analysis of longitudinal studies

Wang S, Zheng X, Huang J, Liu J, Li C, Shang H.

J Neurol. 2024 Jul;271(7):3782-3793. doi: 10.1007/s00415-024-12380-7. Epub 2024 Apr 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias